A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 56
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LMC
Long Form : leptomeningeal carcinomatosis
No. Year Title Co-occurring Abbreviation
2020 CYFRA 21-1 levels in cerebrospinal fluid as a putative therapeutic monitoring biomarker for patients with leptomeningeal carcinomatosis: A pilot study. CSF, ICP, KPS, VLP
2020 Impact of clinicopathologic features on leptomeningeal metastasis from lung adenocarcinoma and treatment efficacy with epidermal growth factor receptor tyrosine kinase inhibitor. CSF, EGFR, HR, i.t, IQR, TKI
2020 Osimertinib Overcomes Alectinib Resistance Caused by Amphiregulin in a Leptomeningeal Carcinomatosis Model of ALK-Rearranged LungCancer. ALK, ALK-TKIs, AREG
2020 Pancreatic cancer with leptomeningeal carcinomatosis: case report and literature review. CA, CT
2019 A case of leptomeningeal carcinomatosis in advanced gastric adenocarcinoma with controlled peritoneal dissemination. ---
2019 Association of MRI findings with clinical characteristics and prognosis in patients with leptomeningeal carcinomatosis from non-small cell lung cancer. MRI, NSCLC, OS
2019 Clinical outcome of cerebrospinal fluid shunts in patients with leptomeningeal carcinomatosis. CSF, IRB, LP, MRI, VP
2019 Leptomeningeal Carcinomatosis as the Initial Manifestation of Metastatic Disease diagnosed in Postmortem Examination: A Case Series. CSF
2019 Leptomeningeal Carcinomatosis from Squamous Cell Carcinoma of the Ethmoid Sinus: A Case Report. SCC
10  2019 Osimertinib in the treatment of leptomeningeal disease in T790M-negative, epidermal growth factor receptor-mutated non-small cell lung cancer: a case report. EGFR, NSCLC, TKI
11  2018 Anorectal Cancer with Bone Marrow and Leptomeningeal Metastases. CRC
12  2017 Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasis. CSF, LMIs, PCA-DA
13  2017 Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis. CSF, VLP
14  2017 Efficacy of bevacizumab and erlotinib combination for leptomeningeal carcinomatosis after failure of erlotinib. EGFR
15  2017 Leptomeningeal carcinomatosis from gastric cancer successfully treated by the intrathecal methotrexate plus temozolomide and simultaneous radiotherapy: Case report and literatures review. CSF
16  2017 Signet Cell in the Brain: A Case Report of Leptomeningeal Carcinomatosis as the Presenting Feature of Gastric Signet Cell Cancer. CSF, PICA, VP
17  2017 Successful osimertinib treatment for leptomeningeal carcinomatosis from lung adenocarcinoma with the T790M mutation of EGFR. EGFR, NSCLC, TKI
18  2016 Cauda Equina Syndrome Secondary to Leptomeningeal Carcinomatosis of Gastroesophageal Junction Cancer. ---
19  2016 High efficacy of third generation EGFR inhibitor AZD9291 in a leptomeningeal carcinomatosis model with EGFR-mutant lung cancer cells. CNS, TKI
20  2016 Leptomeningeal carcinomatosis as primary manifestation of pancreatic cancer. CSF
21  2016 Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future Directions. ALK, EGFR, HER2
22  2016 Retrospective Analysis of Cerebrospinal Fluid Profiles in 228 Patients with Leptomeningeal Carcinomatosis : Differences According to the Sampling Site, Symptoms, and Systemic Factors. CEA, CSF
23  2016 Whole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomeningeal carcinomatosis: evaluation of prognostic factors. BM, ECOG PS, NSCLC, OS, SCC, TT-LMC, WBRT
24  2016 [A Case of Isolated Leptomeningeal Carcinomatosis from Advanced Gastric Cancer]. ---
25  2015 A report of a rare gastric cancer case: leptomeningeal carcinomatosis. CSF
26  2015 Icotinib might be effective for the treatment of leptomeningeal carcinomatosis in non-small cell lung cancer with sensitive EGFR mutations. CI, ECOG PS, NSCLC
27  2015 Intracranial control after Cyberknife radiosurgery to the resection bed for large brain metastases. CK, SRS, WBRT
28  2015 Intravenous thiotepa for treatment of breast cancer-related leptomeningeal carcinomatosis: case series. i.t, MBC, MTX
29  2015 Leptomeningeal metastasis as initial manifestation of signet ring colorectal adenocarcinoma: a case report with review of literature. ---
30  2015 Recent Advancements of Treatment for Leptomeningeal Carcinomatosis. CSF, ICP, MTX, VLP
31  2014 Afatinib combined with cetuximab for lung adenocarcinoma with leptomeningeal carcinomatosis. EGFR, MRI, NSCLC, TKI
32  2014 Leptomeningeal carcinomatosis as the initial manifestation of gastric adenocarcinoma: a case report. ---
33  2014 Leptomeningeal carcinomatosis associated with papillary renal cell carcinoma. RCC
34  2014 Leptomeningeal carcinomatosis from gastric cancer: single institute retrospective analysis of 9 cases. ---
35  2014 Sudden hearing loss due to internal auditory canal metastasis of Her2-positive gastric cancer: A case report. GC, HER2, IAC
36  2014 Ventriculolumbar perfusion chemotherapy with methotrexate for treating leptomeningeal carcinomatosis: a Phase II Study. CSF, ICP, MTX, VLP
37  2013 Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer. ICP
38  2013 Erlotinib versus gefitinib for control of leptomeningeal carcinomatosis in non-small-cell lung cancer. EGFR, NSCLC, TKIs
39  2013 Leptomeningeal carcinomatosis originating from advanced gastric cancer--a report of three cases and review of the literatures. CSF, MRI
40  2013 Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: a retrospective cohort study. i.t, OS, TTP
41  2012 Extensive cortical involvement in leptomeningeal carcinomatosis. ---
42  2012 Incidence and risk factors for leptomeningeal carcinomatosis in breast cancer patients with parenchymal brain metastases. PBM, SR, WBRT
43  2012 Leptomeningeal carcinomatosis as initial presentation in adenocarcinoma of lung with signet ring cell features: an autopsy case report. ALK, CK, PA, PA-SRC, SRC
44  2012 Leptomeningeal carcinomatosis associated with gastric cancer. ---
45  2012 Outcome after whole brain radiotherapy alone in intracranial leptomeningeal carcinomatosis from solid tumors. KPS, OS, WBRT
46  2011 Chemoport with a non-collapsible chamber as a replacement for an Ommaya reservoir in the treatment of leptomeningeal carcinomatosis. CSF, EVD, ICH, ICP
47  2011 Delayed but Complete Response following Oral Temozolomide Treatment in Melanoma Leptomeningeal Carcinomatosis. ---
48  2011 Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis. CNS, i.t, MBC
49  2010 Perineural invasion progressing to leptomeningeal carcinomatosis: is the absence of peripheral nerves an important sign? PNI
50  2009 Gastric leptomeningeal carcinomatosis: multi-center retrospective analysis of 54 cases. i.t
51  2009 Leptomeningeal carcinomatosis presenting as bilateral sensorineural deafness and unilateral facial palsy. MRI
52  2009 Need for a new treatment strategy: leptomeningeal carcinomatosis from gastric cancer. ---
53  2004 Leptomeningeal carcinomatosis in gastric cancer. CT, MRI
54  2002 Isolated leptomeningeal carcinomatosis (carcinomatous meningitis) after taxane-induced major remission in patients with advanced breast cancer. i.t, RT
55  2002 Leptomeningeal carcinomatosis after major remission to taxane-based front-line therapy in patients with advanced breast cancer. i.t, RT
56  1992 Leptomeningeal carcinomatosis following craniofacial resection of an ethmoid tumor. CSF